

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.43730066 |
| 2 | * L-phenylalanine catabolic process (GO:0006559) | 7.43730066 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.28319930 |
| 4 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09980458 |
| 5 | * L-phenylalanine metabolic process (GO:0006558) | 7.09980458 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 6.90659945 |
| 7 | * aromatic amino acid family catabolic process (GO:0009074) | 6.82296367 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.32355459 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.32355459 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.32355459 |
| 11 | glyoxylate metabolic process (GO:0046487) | 6.14324208 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.05009191 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.96184595 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.90441108 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78438920 |
| 16 | cysteine metabolic process (GO:0006534) | 5.78109146 |
| 17 | regulation of plasminogen activation (GO:0010755) | 5.61203315 |
| 18 | urea metabolic process (GO:0019627) | 5.58481607 |
| 19 | urea cycle (GO:0000050) | 5.58481607 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40241834 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.38469427 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.34622560 |
| 23 | lysine metabolic process (GO:0006553) | 5.30895239 |
| 24 | lysine catabolic process (GO:0006554) | 5.30895239 |
| 25 | homocysteine metabolic process (GO:0050667) | 5.22016861 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.20338740 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.15428408 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09045679 |
| 29 | protein activation cascade (GO:0072376) | 5.07888049 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06821428 |
| 31 | protein carboxylation (GO:0018214) | 5.06354502 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06354502 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.05888474 |
| 34 | oxidative demethylation (GO:0070989) | 5.04110823 |
| 35 | regulation of protein activation cascade (GO:2000257) | 5.00367456 |
| 36 | regulation of fibrinolysis (GO:0051917) | 5.00273531 |
| 37 | bile acid metabolic process (GO:0008206) | 4.99474733 |
| 38 | negative regulation of blood coagulation (GO:0030195) | 4.98102549 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.98102549 |
| 40 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.92407345 |
| 41 | intestinal cholesterol absorption (GO:0030299) | 4.91483001 |
| 42 | * aromatic amino acid family metabolic process (GO:0009072) | 4.90119313 |
| 43 | negative regulation of protein activation cascade (GO:2000258) | 4.88734945 |
| 44 | ethanol metabolic process (GO:0006067) | 4.83742707 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.82171682 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.79903711 |
| 47 | * alpha-amino acid catabolic process (GO:1901606) | 4.75594322 |
| 48 | regulation of humoral immune response (GO:0002920) | 4.72554134 |
| 49 | regulation of complement activation (GO:0030449) | 4.68531871 |
| 50 | complement activation (GO:0006956) | 4.60262669 |
| 51 | acute-phase response (GO:0006953) | 4.59964711 |
| 52 | negative regulation of coagulation (GO:0050819) | 4.56138282 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 4.54253511 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.53234321 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.50256395 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 4.49302490 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.48493378 |
| 58 | serine family amino acid metabolic process (GO:0009069) | 4.47599073 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.47148078 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.47148078 |
| 61 | negative regulation of wound healing (GO:0061045) | 4.46889974 |
| 62 | glycine metabolic process (GO:0006544) | 4.45413124 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 4.45265281 |
| 64 | positive regulation of hemostasis (GO:1900048) | 4.45265281 |
| 65 | drug catabolic process (GO:0042737) | 4.45198822 |
| 66 | * cellular amino acid catabolic process (GO:0009063) | 4.42257992 |
| 67 | reverse cholesterol transport (GO:0043691) | 4.42102673 |
| 68 | glutamate metabolic process (GO:0006536) | 4.38949476 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 4.38703164 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.37632447 |
| 71 | negative regulation of sterol transport (GO:0032372) | 4.36239229 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 4.36239229 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.36191781 |
| 74 | amine catabolic process (GO:0009310) | 4.36191781 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.36098071 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 4.36049864 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 4.36049864 |
| 78 | macromolecular complex remodeling (GO:0034367) | 4.36049864 |
| 79 | triglyceride homeostasis (GO:0070328) | 4.34886974 |
| 80 | acylglycerol homeostasis (GO:0055090) | 4.34886974 |
| 81 | cellular glucuronidation (GO:0052695) | 4.31214122 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 4.24372756 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.22051714 |
| 84 | bile acid and bile salt transport (GO:0015721) | 4.21782605 |
| 85 | urate metabolic process (GO:0046415) | 4.21125769 |
| 86 | drug transmembrane transport (GO:0006855) | 4.18111630 |
| 87 | negative regulation of lipase activity (GO:0060192) | 4.17660242 |
| 88 | cytolysis (GO:0019835) | 4.11694483 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 4.10964831 |
| 90 | phospholipid efflux (GO:0033700) | 4.10524445 |
| 91 | ethanol oxidation (GO:0006069) | 4.09977821 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08923300 |
| 93 | positive regulation of coagulation (GO:0050820) | 4.08356192 |
| 94 | regulation of apoptotic cell clearance (GO:2000425) | 4.07356657 |
| 95 | aldehyde catabolic process (GO:0046185) | 4.06929583 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 4.04406028 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 4.03919225 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 4.02751845 |
| 99 | S-adenosylmethionine metabolic process (GO:0046500) | 4.01498633 |
| 100 | arginine metabolic process (GO:0006525) | 3.97303685 |
| 101 | exogenous drug catabolic process (GO:0042738) | 3.95978946 |
| 102 | response to mercury ion (GO:0046689) | 3.94927700 |
| 103 | aspartate family amino acid catabolic process (GO:0009068) | 3.92599586 |
| 104 | ketone body metabolic process (GO:1902224) | 3.92237822 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.91934186 |
| 106 | negative regulation of complement activation (GO:0045916) | 3.90844749 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.89530234 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.89530234 |
| 109 | * carboxylic acid catabolic process (GO:0046395) | 3.88042112 |
| 110 | * organic acid catabolic process (GO:0016054) | 3.88042112 |
| 111 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.84091386 |
| 112 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.84091386 |
| 113 | protein-lipid complex assembly (GO:0065005) | 3.83812068 |
| 114 | cholesterol efflux (GO:0033344) | 3.82557950 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 3.79527443 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76017355 |
| 117 | fibrinolysis (GO:0042730) | 3.74735780 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71092809 |
| 119 | opsonization (GO:0008228) | 3.70093801 |
| 120 | polyketide metabolic process (GO:0030638) | 3.68651273 |
| 121 | doxorubicin metabolic process (GO:0044598) | 3.68651273 |
| 122 | daunorubicin metabolic process (GO:0044597) | 3.68651273 |
| 123 | cofactor catabolic process (GO:0051187) | 3.68546606 |
| 124 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67826165 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.65654296 |
| 126 | alkaloid metabolic process (GO:0009820) | 3.65294380 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 3.63727051 |
| 128 | hormone catabolic process (GO:0042447) | 3.62559660 |
| 129 | phospholipid homeostasis (GO:0055091) | 3.61674864 |
| 130 | cholesterol homeostasis (GO:0042632) | 3.59846782 |
| 131 | monocarboxylic acid catabolic process (GO:0072329) | 3.59585056 |
| 132 | drug metabolic process (GO:0017144) | 3.58694860 |
| 133 | flavonoid metabolic process (GO:0009812) | 3.57899987 |
| 134 | fatty acid oxidation (GO:0019395) | 3.56541406 |
| 135 | fatty acid beta-oxidation (GO:0006635) | 3.56264691 |
| 136 | sterol homeostasis (GO:0055092) | 3.55914576 |
| 137 | carnitine metabolic process (GO:0009437) | 3.54281006 |
| 138 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52845685 |
| 139 | complement activation, classical pathway (GO:0006958) | 3.51073825 |
| 140 | acute inflammatory response (GO:0002526) | 3.50827615 |
| 141 | positive regulation of lipid catabolic process (GO:0050996) | 3.50746194 |
| 142 | sodium-independent organic anion transport (GO:0043252) | 3.49774801 |
| 143 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.49542123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.34910063 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.15657295 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.82944883 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44897385 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19815476 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90959074 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81041828 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99760451 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92342896 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10395330 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09713683 |
| 12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09279120 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7619720 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64186869 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62213451 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45583797 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45119514 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38974557 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26842502 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15904403 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15829750 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14291834 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07306163 |
| 24 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04741109 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04401833 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02429160 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01881084 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00915047 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99931190 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99156998 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96700913 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95971241 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94726707 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91702661 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91686253 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86447847 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85987438 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84090967 |
| 39 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82529310 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80024340 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77747102 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76744340 |
| 43 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76686767 |
| 44 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76002594 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74891366 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74721415 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73961689 |
| 48 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73856813 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72078333 |
| 50 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71537472 |
| 51 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71511519 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70970394 |
| 53 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70124889 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69238111 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68409823 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68233363 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.65351098 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64407157 |
| 59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64244729 |
| 60 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63895235 |
| 61 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63895235 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62634851 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61748556 |
| 64 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61615300 |
| 65 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.60658573 |
| 66 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60442879 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59010060 |
| 68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58897950 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58087755 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57759847 |
| 71 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.57642605 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57132533 |
| 73 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55785500 |
| 74 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.55627797 |
| 75 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55190178 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.54978967 |
| 77 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54778683 |
| 78 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.54108781 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53599966 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.53586647 |
| 81 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52926658 |
| 82 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52919029 |
| 83 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.52765085 |
| 84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.52261093 |
| 85 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.51263197 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50380168 |
| 87 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50348405 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.50322308 |
| 89 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50258580 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50008509 |
| 91 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.49046149 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49022907 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48739701 |
| 94 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.48725041 |
| 95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48362984 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.48338819 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.48291625 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.48283369 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.48277971 |
| 100 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.47904197 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47614661 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.47291298 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46545189 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.46189024 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46026798 |
| 106 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.45805685 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45767172 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.45713190 |
| 109 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.45690496 |
| 110 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45672128 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45459784 |
| 112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44592331 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44516487 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.44460256 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43200626 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41927081 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41517531 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41063755 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.40483543 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40458925 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.40190180 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39810841 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38474716 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38128933 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37676398 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37550353 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.37240805 |
| 128 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37196725 |
| 129 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37098202 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36665758 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.36508924 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36465471 |
| 133 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36350622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.19271675 |
| 2 | MP0005360_urolithiasis | 7.84643402 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29102098 |
| 4 | MP0005365_abnormal_bile_salt | 6.05681341 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09517418 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08582020 |
| 7 | MP0003252_abnormal_bile_duct | 3.96039361 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.34799598 |
| 9 | MP0003195_calcinosis | 3.14267477 |
| 10 | * MP0005332_abnormal_amino_acid | 3.05152675 |
| 11 | MP0005083_abnormal_biliary_tract | 3.04626546 |
| 12 | MP0009840_abnormal_foam_cell | 2.90422402 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.66117821 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.52809806 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.32291031 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.14257450 |
| 17 | MP0000609_abnormal_liver_physiology | 2.06563553 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.04366190 |
| 19 | MP0003868_abnormal_feces_composition | 1.87366874 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.85138309 |
| 21 | MP0001764_abnormal_homeostasis | 1.69277434 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62217708 |
| 23 | * MP0009643_abnormal_urine_homeostasis | 1.54245878 |
| 24 | MP0005451_abnormal_body_composition | 1.48177958 |
| 25 | MP0003186_abnormal_redox_activity | 1.40320036 |
| 26 | MP0009697_abnormal_copulation | 1.35818458 |
| 27 | MP0002132_abnormal_respiratory_system | 1.22848455 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.20278475 |
| 29 | MP0003011_delayed_dark_adaptation | 1.18564094 |
| 30 | MP0000598_abnormal_liver_morphology | 1.15969474 |
| 31 | MP0000566_synostosis | 1.15792837 |
| 32 | MP0001915_intracranial_hemorrhage | 1.15612574 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.14476367 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.08557957 |
| 35 | MP0005647_abnormal_sex_gland | 1.05688628 |
| 36 | MP0009764_decreased_sensitivity_to | 1.05041184 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.00970607 |
| 38 | MP0000604_amyloidosis | 0.97298466 |
| 39 | MP0009763_increased_sensitivity_to | 0.94782431 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.92277022 |
| 41 | MP0005670_abnormal_white_adipose | 0.89854692 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 0.89304038 |
| 43 | MP0001756_abnormal_urination | 0.88975496 |
| 44 | MP0003122_maternal_imprinting | 0.88649161 |
| 45 | MP0008469_abnormal_protein_level | 0.88150750 |
| 46 | MP0002254_reproductive_system_inflammat | 0.87674217 |
| 47 | * MP0009642_abnormal_blood_homeostasis | 0.87641747 |
| 48 | MP0004043_abnormal_pH_regulation | 0.85495305 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.84341835 |
| 50 | MP0010368_abnormal_lymphatic_system | 0.79578858 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.77828178 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.76541538 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.76494396 |
| 54 | MP0005535_abnormal_body_temperature | 0.75545960 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 0.75039190 |
| 56 | MP0002136_abnormal_kidney_physiology | 0.74369291 |
| 57 | MP0003879_abnormal_hair_cell | 0.73831420 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.71206066 |
| 59 | MP0001661_extended_life_span | 0.70244993 |
| 60 | MP0002971_abnormal_brown_adipose | 0.68325368 |
| 61 | MP0004130_abnormal_muscle_cell | 0.64289909 |
| 62 | MP0005334_abnormal_fat_pad | 0.63938821 |
| 63 | MP0002928_abnormal_bile_duct | 0.63704127 |
| 64 | MP0005187_abnormal_penis_morphology | 0.61823625 |
| 65 | MP0005266_abnormal_metabolism | 0.61782869 |
| 66 | MP0003329_amyloid_beta_deposits | 0.61312176 |
| 67 | MP0003690_abnormal_glial_cell | 0.60930725 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.58562132 |
| 69 | MP0009053_abnormal_anal_canal | 0.57050460 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.56314926 |
| 71 | MP0005023_abnormal_wound_healing | 0.53089425 |
| 72 | MP0005395_other_phenotype | 0.51908869 |
| 73 | MP0005448_abnormal_energy_balance | 0.49967032 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.49546609 |
| 75 | MP0004272_abnormal_basement_membrane | 0.47096139 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.45905799 |
| 77 | MP0005164_abnormal_response_to | 0.45905493 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.45622477 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.43905149 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.43665106 |
| 81 | MP0008874_decreased_physiological_sensi | 0.43543734 |
| 82 | MP0002168_other_aberrant_phenotype | 0.43423004 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.43246988 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.42241770 |
| 85 | MP0008873_increased_physiological_sensi | 0.42030040 |
| 86 | MP0004883_abnormal_blood_vessel | 0.41208478 |
| 87 | * MP0003953_abnormal_hormone_level | 0.41008206 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.39843760 |
| 89 | MP0003878_abnormal_ear_physiology | 0.39843760 |
| 90 | MP0003724_increased_susceptibility_to | 0.39793333 |
| 91 | MP0003718_maternal_effect | 0.39484193 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.39320512 |
| 93 | MP0008872_abnormal_physiological_respon | 0.39318871 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.38633538 |
| 95 | MP0009672_abnormal_birth_weight | 0.38438138 |
| 96 | MP0002822_catalepsy | 0.38215175 |
| 97 | MP0003075_altered_response_to | 0.37747709 |
| 98 | * MP0003638_abnormal_response/metabolism_ | 0.37315064 |
| 99 | MP0002796_impaired_skin_barrier | 0.36501778 |
| 100 | MP0005166_decreased_susceptibility_to | 0.36207302 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.34505560 |
| 102 | MP0009384_cardiac_valve_regurgitation | 0.33319730 |
| 103 | MP0002135_abnormal_kidney_morphology | 0.32534748 |
| 104 | MP0003632_abnormal_nervous_system | 0.31935720 |
| 105 | MP0003436_decreased_susceptibility_to | 0.31797767 |
| 106 | MP0005409_darkened_coat_color | 0.31278968 |
| 107 | MP0000920_abnormal_myelination | 0.31184052 |
| 108 | MP0000538_abnormal_urinary_bladder | 0.30606685 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.30303206 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.29839961 |
| 111 | MP0009115_abnormal_fat_cell | 0.29577662 |
| 112 | MP0000579_abnormal_nail_morphology | 0.29566371 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.28948071 |
| 114 | MP0003959_abnormal_lean_body | 0.28857262 |
| 115 | * MP0005408_hypopigmentation | 0.27994680 |
| 116 | MP0002970_abnormal_white_adipose | 0.27413235 |
| 117 | MP0004381_abnormal_hair_follicle | 0.27365783 |
| 118 | MP0006082_CNS_inflammation | 0.26938821 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.26580522 |
| 120 | MP0003943_abnormal_hepatobiliary_system | 0.26417982 |
| 121 | MP0005410_abnormal_fertilization | 0.25566433 |
| 122 | MP0000249_abnormal_blood_vessel | 0.25505599 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.25182124 |
| 124 | MP0009785_altered_susceptibility_to | 0.24869373 |
| 125 | MP0002128_abnormal_blood_circulation | 0.24307537 |
| 126 | MP0003123_paternal_imprinting | 0.23168255 |
| 127 | MP0003633_abnormal_nervous_system | 0.22082738 |
| 128 | MP0003631_nervous_system_phenotype | 0.21287856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.00494250 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.83801440 |
| 3 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.77846579 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.43384646 |
| 5 | Xanthomatosis (HP:0000991) | 6.03700782 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.96794883 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.87767181 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.10900505 |
| 9 | Complement deficiency (HP:0004431) | 4.97020263 |
| 10 | Hyperammonemia (HP:0001987) | 4.72430420 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.70835482 |
| 12 | Hyperglycinemia (HP:0002154) | 4.60629162 |
| 13 | Ketosis (HP:0001946) | 4.52015264 |
| 14 | Hyperglycinuria (HP:0003108) | 4.47728765 |
| 15 | Joint hemorrhage (HP:0005261) | 4.43560310 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.37510386 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.37320259 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.34406068 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.32489382 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.32489382 |
| 21 | Epidermoid cyst (HP:0200040) | 4.26764718 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.13136215 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.12348833 |
| 24 | Fat malabsorption (HP:0002630) | 4.03279175 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.01095626 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.80047809 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.79266887 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79140138 |
| 29 | Nephritis (HP:0000123) | 3.78172687 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58824910 |
| 31 | Abnormality of complement system (HP:0005339) | 3.58782082 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56533322 |
| 33 | Gout (HP:0001997) | 3.55896926 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51053650 |
| 35 | Ketoacidosis (HP:0001993) | 3.42955520 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.41980914 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.35252115 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.32106654 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28525054 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.23938140 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.23401302 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.21040261 |
| 43 | Steatorrhea (HP:0002570) | 3.05915298 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.01680372 |
| 45 | Osteomalacia (HP:0002749) | 2.95071074 |
| 46 | Metabolic acidosis (HP:0001942) | 2.93986831 |
| 47 | Purpura (HP:0000979) | 2.83914252 |
| 48 | Vascular calcification (HP:0004934) | 2.83070268 |
| 49 | Lethargy (HP:0001254) | 2.78764542 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.77800471 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77800471 |
| 52 | Myocardial infarction (HP:0001658) | 2.72951228 |
| 53 | Spontaneous abortion (HP:0005268) | 2.65948189 |
| 54 | Skin nodule (HP:0200036) | 2.62526543 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.62491641 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.62177093 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.58003053 |
| 58 | Alkalosis (HP:0001948) | 2.57814580 |
| 59 | Spastic diplegia (HP:0001264) | 2.55662940 |
| 60 | Cerebral edema (HP:0002181) | 2.52716794 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.51029367 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.47845183 |
| 63 | Neonatal onset (HP:0003623) | 2.46164856 |
| 64 | Hyperuricemia (HP:0002149) | 2.42594051 |
| 65 | Increased purine levels (HP:0004368) | 2.42594051 |
| 66 | Malnutrition (HP:0004395) | 2.40073218 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.35560312 |
| 68 | Enlarged kidneys (HP:0000105) | 2.34095687 |
| 69 | Acanthocytosis (HP:0001927) | 2.33255543 |
| 70 | Mitral stenosis (HP:0001718) | 2.31067196 |
| 71 | Vomiting (HP:0002013) | 2.30159313 |
| 72 | * Irritability (HP:0000737) | 2.29586821 |
| 73 | Arthropathy (HP:0003040) | 2.28800481 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.27397656 |
| 75 | Pulmonary embolism (HP:0002204) | 2.25787839 |
| 76 | Glomerulonephritis (HP:0000099) | 2.24839699 |
| 77 | Hydroxyprolinuria (HP:0003080) | 2.23918383 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.23918383 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.22905714 |
| 80 | Pancreatitis (HP:0001733) | 2.22346122 |
| 81 | Cholelithiasis (HP:0001081) | 2.21782704 |
| 82 | Rickets (HP:0002748) | 2.21104873 |
| 83 | Late onset (HP:0003584) | 2.19742814 |
| 84 | Glycosuria (HP:0003076) | 2.16043608 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.16043608 |
| 86 | Esophageal varix (HP:0002040) | 2.13689349 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12999129 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.11717329 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.11142373 |
| 90 | Cholecystitis (HP:0001082) | 2.11142373 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 2.09047833 |
| 92 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.07945898 |
| 93 | Hyperphosphaturia (HP:0003109) | 2.06055084 |
| 94 | Brushfield spots (HP:0001088) | 2.02654553 |
| 95 | Opisthotonus (HP:0002179) | 2.01288806 |
| 96 | Bifid scrotum (HP:0000048) | 2.00431852 |
| 97 | Amyloidosis (HP:0011034) | 1.99163804 |
| 98 | Thrombophlebitis (HP:0004418) | 1.96975368 |
| 99 | Menorrhagia (HP:0000132) | 1.96410646 |
| 100 | Facial shape deformation (HP:0011334) | 1.96228890 |
| 101 | Potter facies (HP:0002009) | 1.96228890 |
| 102 | Hypophosphatemic rickets (HP:0004912) | 1.95951365 |
| 103 | Poikilocytosis (HP:0004447) | 1.95654006 |
| 104 | Joint swelling (HP:0001386) | 1.92420988 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.91593114 |
| 106 | Abnormal tarsal ossification (HP:0008369) | 1.90417027 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89256385 |
| 108 | Gingival bleeding (HP:0000225) | 1.88903801 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 1.88546708 |
| 110 | Renal cortical cysts (HP:0000803) | 1.84249078 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83200803 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.81735328 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.81245745 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.81010131 |
| 115 | Increased serum pyruvate (HP:0003542) | 1.80217330 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80186037 |
| 117 | Epistaxis (HP:0000421) | 1.78650712 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.70556577 |
| 119 | Abnormality of carpal bone ossification (HP:0006257) | 1.67680890 |
| 120 | Increased serum ferritin (HP:0003281) | 1.67245492 |
| 121 | Abnormal delivery (HP:0001787) | 1.65275414 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.64650196 |
| 123 | Gangrene (HP:0100758) | 1.64465424 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.61863754 |
| 125 | Abnormality of glycolysis (HP:0004366) | 1.56630217 |
| 126 | Neonatal hypoglycemia (HP:0001998) | 1.55907447 |
| 127 | Abnormal platelet function (HP:0011869) | 1.47168597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.51310684 |
| 2 | FGFR4 | 4.29296397 |
| 3 | SIK1 | 4.06418832 |
| 4 | ERN1 | 4.00419963 |
| 5 | INSRR | 2.91960841 |
| 6 | ERBB4 | 2.74018503 |
| 7 | TAOK3 | 2.66390625 |
| 8 | PIK3CA | 2.43155990 |
| 9 | MST1R | 2.23595138 |
| 10 | MAP2K4 | 2.13352787 |
| 11 | CDK12 | 2.10490505 |
| 12 | WNK4 | 2.08675404 |
| 13 | PKN2 | 2.05538975 |
| 14 | MAPK11 | 1.86622205 |
| 15 | WNK3 | 1.84967061 |
| 16 | TRIB3 | 1.67641524 |
| 17 | FLT3 | 1.67460177 |
| 18 | FGFR1 | 1.66182066 |
| 19 | LATS1 | 1.65201192 |
| 20 | PIK3CG | 1.64709990 |
| 21 | FRK | 1.61856527 |
| 22 | NTRK3 | 1.61372900 |
| 23 | MAP3K2 | 1.60263902 |
| 24 | OXSR1 | 1.53405061 |
| 25 | TYK2 | 1.50936162 |
| 26 | STK38L | 1.48777901 |
| 27 | ABL2 | 1.48535987 |
| 28 | AKT3 | 1.43812247 |
| 29 | PTK6 | 1.41246618 |
| 30 | PDGFRA | 1.40278857 |
| 31 | PINK1 | 1.30189995 |
| 32 | NEK9 | 1.30156428 |
| 33 | DAPK2 | 1.29201671 |
| 34 | MAP3K7 | 1.25428382 |
| 35 | FGFR2 | 1.23295164 |
| 36 | JAK2 | 1.13666918 |
| 37 | PRKAA2 | 1.13149399 |
| 38 | EPHA2 | 1.13001973 |
| 39 | KDR | 1.11520473 |
| 40 | GRK6 | 1.11391033 |
| 41 | EIF2AK1 | 1.01838038 |
| 42 | MAP2K3 | 0.97455036 |
| 43 | MAP3K14 | 0.93843940 |
| 44 | ERBB2 | 0.92942996 |
| 45 | PRKCZ | 0.91661467 |
| 46 | MAP3K3 | 0.89481592 |
| 47 | TYRO3 | 0.88597429 |
| 48 | TBK1 | 0.88150296 |
| 49 | EPHB1 | 0.86926288 |
| 50 | BRSK2 | 0.86717242 |
| 51 | MAPK4 | 0.86078326 |
| 52 | JAK1 | 0.85967329 |
| 53 | MET | 0.85499606 |
| 54 | SGK3 | 0.82814155 |
| 55 | TIE1 | 0.81515602 |
| 56 | MAPK15 | 0.80202841 |
| 57 | MAP3K10 | 0.80109392 |
| 58 | SGK494 | 0.79438437 |
| 59 | SGK223 | 0.79438437 |
| 60 | GSK3A | 0.79229195 |
| 61 | PDK3 | 0.77528370 |
| 62 | PDK4 | 0.77528370 |
| 63 | DYRK1B | 0.75985763 |
| 64 | MAPK12 | 0.75105224 |
| 65 | CSNK1E | 0.75089884 |
| 66 | SGK1 | 0.74289033 |
| 67 | MAP3K1 | 0.73860766 |
| 68 | PRKAA1 | 0.73098230 |
| 69 | NLK | 0.72485669 |
| 70 | KSR2 | 0.70012157 |
| 71 | SGK2 | 0.69948210 |
| 72 | CDK6 | 0.67748925 |
| 73 | PRKG1 | 0.67047958 |
| 74 | CSNK1D | 0.64973093 |
| 75 | TGFBR2 | 0.63974568 |
| 76 | IRAK3 | 0.63695850 |
| 77 | LATS2 | 0.63512800 |
| 78 | MAP3K11 | 0.63134439 |
| 79 | MAPKAPK3 | 0.62261475 |
| 80 | MAP2K6 | 0.62005380 |
| 81 | * PRKACG | 0.60594623 |
| 82 | CSK | 0.60542675 |
| 83 | PTK2 | 0.60492327 |
| 84 | CAMK2G | 0.60487395 |
| 85 | PDPK1 | 0.57428799 |
| 86 | RIPK1 | 0.57060805 |
| 87 | WNK1 | 0.55598493 |
| 88 | CAMK1D | 0.55455171 |
| 89 | BCR | 0.55234526 |
| 90 | EPHA3 | 0.54885530 |
| 91 | SIK2 | 0.54437958 |
| 92 | FER | 0.53696964 |
| 93 | RPS6KB1 | 0.52727698 |
| 94 | STK39 | 0.52241187 |
| 95 | MAP3K12 | 0.51680857 |
| 96 | SCYL2 | 0.50193422 |
| 97 | CDK7 | 0.49034450 |
| 98 | FGFR3 | 0.49020433 |
| 99 | CAMKK2 | 0.48684416 |
| 100 | MAPK7 | 0.48189987 |
| 101 | SRC | 0.47507315 |
| 102 | NEK1 | 0.46028406 |
| 103 | PRKCQ | 0.45634740 |
| 104 | PRKCB | 0.44566741 |
| 105 | EEF2K | 0.44465805 |
| 106 | CSNK1G1 | 0.44216964 |
| 107 | DDR2 | 0.43611274 |
| 108 | IKBKE | 0.42334736 |
| 109 | * PRKACA | 0.41542490 |
| 110 | GRK1 | 0.41297191 |
| 111 | PDK2 | 0.41249372 |
| 112 | IGF1R | 0.41005955 |
| 113 | MAP2K1 | 0.40548527 |
| 114 | CSF1R | 0.40520936 |
| 115 | EPHA4 | 0.40301551 |
| 116 | PRPF4B | 0.39913853 |
| 117 | PRKACB | 0.38977607 |
| 118 | MAP3K5 | 0.38280467 |
| 119 | CSNK2A1 | 0.38085028 |
| 120 | MAP3K13 | 0.37872654 |
| 121 | CSNK2A2 | 0.36831149 |
| 122 | PDK1 | 0.36823732 |
| 123 | * RPS6KA3 | 0.36743495 |
| 124 | IRAK2 | 0.35837089 |
| 125 | TAOK2 | 0.35179893 |
| 126 | PRKCG | 0.34913551 |
| 127 | STK38 | 0.33694815 |
| 128 | RET | 0.33199850 |
| 129 | BRSK1 | 0.32997933 |
| 130 | MTOR | 0.32556475 |
| 131 | IRAK1 | 0.30968936 |
| 132 | PKN1 | 0.30311964 |
| 133 | MAP3K6 | 0.29801241 |
| 134 | CDK4 | 0.29272253 |
| 135 | EGFR | 0.28643546 |
| 136 | MAP2K2 | 0.27697548 |
| 137 | PAK3 | 0.26240157 |
| 138 | PRKCA | 0.25797426 |
| 139 | CAMK4 | 0.25427292 |
| 140 | ICK | 0.24564518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.36535838 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55942384 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49601497 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03428487 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77173004 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74688367 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61980829 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61612880 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56622194 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54262541 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53914887 |
| 12 | * Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53383579 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40471650 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35137709 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.17897755 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14954184 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10243187 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89258938 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87704965 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87076686 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85290568 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83033015 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83001771 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79826462 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79332353 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77562076 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71400681 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70740255 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67204621 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66405787 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62822986 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59660819 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57124805 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.54085304 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51392859 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41880602 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39296798 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37287133 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33737602 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32885224 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29086741 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27725954 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24686953 |
| 44 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23439160 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22732828 |
| 46 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17042574 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16765424 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16533808 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.13529404 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12798889 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11810987 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06048872 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02859321 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00921496 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93535761 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.88891494 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88718787 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83470843 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83432518 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76511498 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76144130 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75221314 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72880278 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71599792 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58323939 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48411814 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43013412 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.37950724 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30091216 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30077648 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.28614375 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27720450 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23824495 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23497211 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22190381 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20911790 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20250890 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17364923 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11666761 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08700961 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02401107 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2377793 |
| 83 | Lysosome_Homo sapiens_hsa04142 | -0.2194402 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2130981 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2095842 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2022813 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1871702 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1792799 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1786934 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1725963 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | -0.1704417 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1683577 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1336862 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1283817 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1232477 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1218739 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1188816 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1179151 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1161603 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0988574 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0948631 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0928364 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0921927 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0838973 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0801609 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.0579976 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0334322 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0242947 |

